We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Financials 13%
3 Technology 12.06%
4 Communication Services 9.43%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
51
Protagonist Therapeutics
PTGX
$9.46B
$105M 0.43%
2,329,680
-95,320
-4% -$3.15M
BPMC
52
DELISTED
Blueprint Medicines
BPMC
$99M 0.4%
1,125,000
+430,209
+62% +$39.4M
APLS
53
DELISTED
Apellis Pharmaceuticals
APLS
$98M 0.4%
1,550,000
-625,000
-29% -$32.3M
GBIO
54
DELISTED
Generation Bio
GBIO
$94.2M 0.38%
350,000
+22,950
+7% +$6.87M
ENTA icon
55
Enanta Pharmaceuticals
ENTA
$388M
$87.8M 0.36%
1,995,000
– –
RVMD icon
56
Revolution Medicines
RVMD
$42.4B
$79.3M 0.32%
2,500,000
+890,270
+55% +$31.1M
PCG icon
57
PG&E
PCG
$37.4B
$74.2M 0.3%
7,292,042
– –
KRTX
58
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$71.8M 0.29%
630,000
-45,000
-7% -$5.26M
AGIO icon
59
Agios Pharmaceuticals
AGIO
$1.91B
$63.9M 0.26%
1,160,000
-90,000
-7% -$5.03M
CHNG
60
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$63.1M 0.26%
2,738,600
+1,285,000
+88% +$29.6M
BRMK
61
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$62.3M 0.25%
5,880,000
-1,290,213
-18% -$13.7M
PLYA
62
DELISTED
Playa Hotels & Resorts
PLYA
$62.1M 0.25%
8,352,553
-6,642,314
-44% -$49M
ARNA
63
DELISTED
Arena Pharmaceuticals Inc
ARNA
$58M 0.24%
850,000
– –
ATTO
64
DELISTED
Atento S.A.
ATTO
$57.2M 0.23%
2,230,357
– –
CYTK icon
65
Cytokinetics
CYTK
$11B
$56.9M 0.23%
2,876,000
+376,000
+15% +$8.83M
NTRA icon
66
Natera
NTRA
$38B
$56.8M 0.23%
+500,000
New +$51.1M
PFPT
67
DELISTED
Proofpoint, Inc.
PFPT
$52.9M 0.22%
+304,500
New +$49.4M
ASND icon
68
Ascendis Pharma A/S
ASND
$16.4B
$49.3M 0.2%
375,000
-625,000
-63% -$83.3M
HZNP
69
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$46.8M 0.19%
+500,000
New +$46M
AVTR icon
70
Avantor
AVTR
$8.91B
$46.3M 0.19%
+1,305,000
New +$42.2M
GPOR icon
71
Gulfport Energy Corp
GPOR
$2.8B
$45.1M 0.18%
+697,444
New +$44.7M
ZGNX
72
DELISTED
Zogenix, Inc.
ZGNX
$38.9M 0.16%
2,250,000
– –
RDUS
73
DELISTED
Radius Health, Inc.
RDUS
$38.4M 0.16%
2,107,400
– –
KYNB
74
Kyntra Bio
KYNB
$28.3M
$38.3M 0.16%
57,557
-9,791
-15% -$5.64M
BCAB icon
75
BioAtla
BCAB
$5.53M
$38.2M 0.16%
18,043
-11,798
-40% -$26.7M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Farallon Capital Management held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Farallon Capital Management deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Farallon Capital Management's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Farallon Capital Management's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Farallon Capital Management fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Farallon Capital Management opened 164 new positions and closed 100 in Q2 2021.
  • Farallon Capital Management's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.